Literature DB >> 23278524

Pharmacokinetic analysis of oral doxycycline in rhesus macaques.

Monica E Embers1, Nicole R Hasenkampf, Dale G Embers, Lara A Doyle.   

Abstract

BACKGROUND: Following administration of an antibiotic, the concentration in blood changes over time and is dependent on the type of antibiotic, the route and species of the individual. The most relevant pharmacodynamic property of a bacteriostatic antibiotic such as doxycycline is the minimum inhibitory concentration (MIC), whereas pharmacokinetics may include rates of absorption and elimination from blood.
METHODS: We determined serum concentrations of doxycycline following administration of 5 mg/kg in two macaques.
RESULTS: The area under the concentration-time curve over 24 hours (AUC0-24 ) following two doses was extrapolated from the curve over 12 hours following a single dose, with the purpose of calculating the AUC0-24 :MIC.
CONCLUSIONS: Other than a somewhat faster rate of elimination, the PK-PD values for doxycycline in macaques appears similar to those determined for humans. This information will be valuable for treating disease in macaques and for research in bacterial infection models that use macaques.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23278524      PMCID: PMC3593953          DOI: 10.1111/jmp.12031

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  16 in total

Review 1.  Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.

Authors:  Kenneth N Agwuh; Alasdair MacGowan
Journal:  J Antimicrob Chemother       Date:  2006-07-01       Impact factor: 5.790

2.  In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.

Authors:  R Baradaran-Dilmaghani; G Stanek
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

3.  In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.

Authors:  Martin Sicklinger; Ralf Wienecke; Uwe Neubert
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.

Authors:  Klaus-Peter Hunfeld; Eva Ruzic-Sabljic; Douglas E Norris; Peter Kraiczy; Franc Strle
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

6.  Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.

Authors:  Paul G Ambrose; Sujata M Bhavnani; Christopher M Rubino; Arnold Louie; Tawanda Gumbo; Alan Forrest; George L Drusano
Journal:  Clin Infect Dis       Date:  2006-11-27       Impact factor: 9.079

Review 7.  Animal models of Lyme disease: pathogenesis and immunoprophylaxis.

Authors:  M T Philipp; B J Johnson
Journal:  Trends Microbiol       Date:  1994-11       Impact factor: 17.079

8.  Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys.

Authors:  D J Kelly; J D Chulay; P Mikesell; A M Friedlander
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

Review 9.  Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.

Authors:  David Andes; Jack Anon; Michael R Jacobs; William A Craig
Journal:  Clin Lab Med       Date:  2004-06       Impact factor: 1.935

10.  Pharmacodynamics of doxycycline for chemoprophylaxis of Lyme disease: preliminary findings and possible implications for other antimicrobials.

Authors:  Jooyun Lee; Gary P Wormser
Journal:  Int J Antimicrob Agents       Date:  2008-01-15       Impact factor: 5.283

View more
  4 in total

1.  Critical analysis of a doxycycline treatment trial of rhesus macaques infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Susan O'Connell; Andrew R Pachner; Ira Schwartz; Eugene D Shapiro; Gerold Stanek; Franc Strle
Journal:  Diagn Microbiol Infect Dis       Date:  2018-06-18       Impact factor: 2.803

Review 2.  Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.

Authors:  Felipe C Cabello; Monica E Embers; Stuart A Newman; Henry P Godfrey
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

3.  Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding.

Authors:  Monica E Embers; Nicole R Hasenkampf; Mary B Jacobs; Amanda C Tardo; Lara A Doyle-Meyers; Mario T Philipp; Emir Hodzic
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

4.  Late Disseminated Lyme Disease: Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques.

Authors:  Nicholas A Crossland; Xavier Alvarez; Monica E Embers
Journal:  Am J Pathol       Date:  2017-12-12       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.